The word "stable" appeared regarding a patient from Cohort 1 who had been on the lowest 2mg dose for 6 months being moved to Cohort 2 announced 28th March 2023. At the time this seemed quite significant to me.
Perhaps the ALSFRS-R will reveal a few surprises. MT was very enthusiastic at his EGM presentation. Could it be that there will be a couple of outliers in the data exceeding even the wildest expectations? I certainly hope so.
The word "stable" appeared regarding a patient from Cohort 1 who...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |